ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 194 filers reported holding ARRAY BIOPHARMA INC in Q4 2017. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $17,687,000 | +5623.9% | 381,771 | +2909.9% | 0.12% | +3966.7% |
| Q1 2019 | $309,000 | +67.9% | 12,684 | +15.6% | 0.00% | +50.0% |
| Q2 2018 | $184,000 | -29.8% | 10,973 | -31.7% | 0.00% | 0.0% |
| Q1 2018 | $262,000 | -70.2% | 16,065 | -77.6% | 0.00% | -75.0% |
| Q3 2017 | $880,000 | +490.6% | 71,582 | +301.0% | 0.01% | +700.0% |
| Q2 2017 | $149,000 | -58.3% | 17,851 | -55.4% | 0.00% | -66.7% |
| Q1 2017 | $357,000 | -38.3% | 39,987 | -39.3% | 0.00% | -40.0% |
| Q4 2016 | $579,000 | +751.5% | 65,926 | +555.3% | 0.01% | +400.0% |
| Q3 2016 | $68,000 | +15.3% | 10,061 | -49.9% | 0.00% | – |
| Q1 2016 | $59,000 | -61.9% | 20,080 | -40.9% | 0.00% | -100.0% |
| Q3 2015 | $155,000 | +55.0% | 34,003 | +144.5% | 0.00% | 0.0% |
| Q2 2015 | $100,000 | -19.4% | 13,907 | -17.1% | 0.00% | 0.0% |
| Q1 2015 | $124,000 | +20.4% | 16,779 | -22.7% | 0.00% | 0.0% |
| Q4 2014 | $103,000 | -24.8% | 21,700 | -1.4% | 0.00% | 0.0% |
| Q3 2013 | $137,000 | -60.2% | 22,007 | -71.0% | 0.00% | -50.0% |
| Q2 2013 | $344,000 | – | 75,819 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 15,978,580 | $268,121,000 | 9.11% |
| BVF INC/IL | 4,672,195 | $78,399,000 | 7.65% |
| First Light Asset Management, LLC | 2,391,575 | $40,131,000 | 6.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 694,500 | $11,647,000 | 4.47% |
| Copernicus Capital Management, LLC | 286,797 | $4,812,000 | 3.49% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 225,511 | $3,784,000 | 3.00% |
| SECTORAL ASSET MANAGEMENT INC | 1,566,477 | $26,285,000 | 2.94% |
| X-Square Capital, LLC | 173,802 | $2,917,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,618,654 | $43,941,000 | 1.48% |
| Birchview Capital, LP | 128,000 | $2,148,000 | 1.46% |